Chris Sampson

Principal Economist | OHE

Chris’s primary research interest is economic evaluation in health care, including health technology assessment policy, the development of new methods for cost-effectiveness analysis, and the valuation of health. He has worked on trial- and model-based economic evaluations in a variety of clinical fields. Chris is also dedicated to building new platforms for collaboration in the discipline of health economics.

Since 2010, Chris has worked alongside randomised trials and other clinical studies in a diverse range of fields including depression, orthotics, neonatology, ADHD, and stroke. His main expertise is in the collection and analysis of patient-reported outcomes and resource-use data. Chris has developed and led methodological studies on the measurement of health-related quality of life, employing both qualitative and quantitative research methods. For his PhD research, he evaluated risk-based screening in the context of the NHS Diabetic Eye Screening Programme. This study incorporated trial data collection, the development of a decision-analytic model, and the design of a framework for individualised cost-effectiveness analysis.

Chris holds several roles that enable him to contribute to the health economics community more widely. He manages and edits The Academic Health Economists’ Blog and regularly contributes to a variety of other blogs and websites. Chris is also closely involved with the UK Health Economists’ Study Group, for which he holds the role of webmaster.

Chris joined the Office of Health Economics in October 2017. Prior to this he worked as a health economist for the University of Nottingham, where he also obtained his PhD. He has a BA in Economics and an MSc in Economics & Health Economics from the University of Sheffield.